Background An increase in cough reflex sensitivity to capsaicin in COPD has been described in some studies, suggesting a role for TRPV1 in the disease phenotype. We utilised a guinea-pig cigarette-smoke (CS) exposure COPD model to investigate an enhanced cough phenotype, and evaluate the role of TRPV1 using a novel clinical-ready inhibitor, XEN-D0501.1 Furthermore, we confirmed enhanced cough responses in COPD patients using a dose-response capsaicin challenge to determine EMax.
Methods Guinea-pigs were exposed to air/cigarette smoke (CS) for 1 h, twice daily, for 8 days. Coughs evoked by aerosolised capsaicin (30 μM), depolarisation of isolated vagus nerve tissue induced by capsaicin (1 μM), or increases in intracellular calcium [Ca2+]i to capsaicin (1 μM) in airway-terminating (i.n. DiI stained) jugular and nodose neurons were evaluated. Vagus nerve was obtained from human non-smoker/smoker subjects for similar assessment. Coughs evoked by capsaicin (4 inhalations, 0.49–1000 µM) were recorded in COPD and compared with healthy controls.
Results Capsaicin-evoked cough was increased in COPD patients (Fig.1A) and in CS-exposed guinea-pigs (Fig.1B) compared to controls. Capsaicin induced greater depolarisation in nerve tissue from CS-exposed guinea-pigs, and in human vagus nerves from smokers, compared to controls. Capsaicin also induced greater [Ca2+]i increases in airway-terminating jugular and nodose (which are normally capsaicin-unresponsive) neurons from CS-exposed guinea-pigs. XEN-D0501 (i.p. 1 h before cough recording) almost completely inhibited the cough response to capsaicin in both air- and CS-exposed guinea-pigs (Fig.1B).
Conclusions CS-exposure evoked increased cough to capsaicin in guinea-pigs, mimicking the enhanced cough phenotype observed in COPD patients. This was paralleled by enhanced capsaicin responses in isolated vagus nerves and airway neurons from CS-exposed guinea-pigs and in human vagus from smokers suggesting the enhanced cough phenotype is due to increased TRPV1-mediated sensory nerve responsiveness. Inhibition of the CS-enhanced cough response by XEN-D0501 further implicated a role for TRPV1. This data, together with the finding that TRPV1 KO mice display less inflammation in a similar pre-clinical model of CS-exposure2, indicates the potential utility of TRPV1 antagonists in the treatment of COPD, which is currently being evaluated in an ongoing COPD clinical trial.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.